✦ LIBER ✦
PIH11 IMPACT OF THE RISK SCORING MODEL ON THE COST-EFFECTIVENESS OF PALIVIZUMAB FOR RESPIRATORY SYNCYTIALVIRUS PROPHYLAXIS IN PREMATURE INFANTS WITH A GESTATIONAL AGE OF 32-35 WEEKS IN CANADA
✍ Scribed by KL Lanctot; B Paes; PL Francis; A Chiu; C Hui; PL Oh
- Book ID
- 118609479
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 90 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1098-3015
No coin nor oath required. For personal study only.